Adversity is less terrifying than hope: Lyell Immunopharma Inc (LYEL)

With 0.53 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.0 million shares. The 52-week range on LYEL shows that it touched its highest point at $3.97 and its lowest point at $1.32 during that stretch. It currently has a 1-year price target of $6.67. Beta for the stock currently stands at -0.56.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of LYEL was up-trending over the past week, with a rise of 8.33%, but this was down by -32.25% over a month. Three-month performance surged to 7.22% while six-month performance rose 41.50%. The stock lost -3.26% in the past year, while it has gained 7.22% so far this year. A look at the trailing 12-month EPS for LYEL yields -0.94 with Next year EPS estimates of -0.89. For the next quarter, that number is -0.21. This implies an EPS growth rate of 8.52% for this year and -5.12% for next year. EPS is expected to decline by -7.90% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -15.28%.

Float and Shares Shorts:

At present, 253.96 million LYEL shares are outstanding with a float of 116.53 million shares on hand for trading. On Mar 15, 2024, short shares totaled 10.38 million, which was 4.08% higher than short shares on Feb 15, 2024.

Institutional Ownership:

Through their ownership of 72.86% of LYEL’s outstanding shares, institutional investors have majority control over the company.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for LYEL since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.

Dividends & Yield:

In terms of dividends, LYEL has a current ratio of $––, which is $–– over the trailing 12-months, while a dividend of $–– is likely to be paid on average over the next five years. Dividend yield is another indicator that appeals to many investors, and LYEL currently yields $0.00. In the past year, LYEL’s dividend yield has been $0.00, but when looking at the stock over the past five years, its yield has been $–. Accordingly, LYEL has a current buyback yield of $0.00. This was $0.00 for the TTM, and it was $– for the past five years.